Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Quantum Dot Technology Extends Clinical Cancer Tools

By LabMedica International staff writers
Posted on 08 Sep 2010
Microneedles that deliver "quantum dots" into human skin could assist the diagnosing and treatment of a variety of medical conditions, including skin cancer.

Researchers from North Carolina State University (NCSU, Raleigh, USA) used a laser-based rapid prototyping approach to create microneedles of varying lengths and shapes, based on two-photon polymerization of an acrylate-based polymer, which enabled the fabrication of hollow, plastic, microneedles with specific design characteristics. More...
These were then used to deliver the quantum dots, nanoscale sized semiconductor crystal dyes with unique properties in terms of light emission that hold promise as a powerful tool in medical diagnosis and theranostics-based clinical applications.

The researchers then tested the plastic microneedle delivery system using pig skin, which has characteristics closely resembling human skin. Using a water-based solution containing the quantum dots, the researchers were able to capture images of the dots entering the skin using multiphoton microscopy. The images allowed the researchers to verify the effectiveness of the microneedles as a delivery mechanism. The study was published in the September 2010 issue of Faraday Discussions.

"Our use of this fabrication technology highlights its potential for other small-scale medical device applications," said lead author Professor Roger Narayan, Ph.D., of the department of biomedical engineering. "Our findings are significant, in part, because this technology will potentially enable researchers to deliver quantum dots, suspended in solution, to deeper layers of skin. That could be useful for the diagnosis and treatment of skin cancers, among other conditions."

Quantum dots have been found to be superior to traditional organic dyes on several counts, one of the most immediately obvious being brightness; it has been estimated that quantum dots are 20 times brighter and 100 times more stable than traditional fluorescent dyes. The use of quantum dots for highly sensitive cellular imaging has seen major advances over the past decade, allowing the acquisition of many consecutive focal-plane images that can be reconstructed into a high-resolution three-dimensional image. Another application that takes advantage of the extraordinary photostability of quantum dot probes is the real-time tracking of molecules and cells over extended periods of time; researchers were able to observe quantum dots in lymph nodes of mice for more than 4 months.

Related Links:

North Carolina State University



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.